Analysts Slash Their PTs on Oracle as They Did Not Buy Its Growth Story

Analysts Slash Their PTs on Oracle as They Did Not Buy Its Growth Story
The Oracle logo is shown on an office building in Irvine, Calif., on June 28, 2018. (Mike Blake/Reuters)
Benzinga
3/14/2022
Updated:
3/14/2022

Analysts slashed their price targets on Oracle Corp post Q3 results.

Piper Sandler analyst Brent Bracelin downgraded to Underweight from Neutral with a PT of $70 (8.7 percent downside), down from $100.

Bracelin found it challenging to reach double-digit organic growth next year, sustaining a cloud shift considering more than 70 percent of revenue came from the traditional Oracle product categories.

BofA analyst Brad Sills lowered the PT to $90 from $105 (17.4 percent upside) and kept a Neutral.

Sills also did not buy the company’s cloud outlook and margin expansion story.

Wolfe Research analyst Alex Zukin lowered the PT to $83 from $105 (8.3 percent upside) peer multiple contractions and kept a Peer Perform.

Zukin noted “strong” fiscal Q3 results with accelerating constant-currency revenue coupled with double-digit sales growth and expanding margins for fiscal 2023.

By Anusuya Lahiri
© 2021 The Epoch Times. The Epoch Times does not provide investment advice. All rights reserved.